久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Launch of Anticancer Agent Halaven in China firstwordpharma
    January 11, 2020
    Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has launched the in-house developed anticancer agent Halaven(R) (generic name: eribulin mesylate) in China.
PharmaSources Customer Service